BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2249047)

  • 1. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.
    Scott J; Johnston I; Britton J
    BMJ; 1990 Nov; 301(6759):1015-7. PubMed ID: 2249047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.
    Hubbard R; Lewis S; Richards K; Johnston I; Britton J
    Lancet; 1996 Feb; 347(8997):284-9. PubMed ID: 8569361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis.
    Hubbard R
    Eur Respir J Suppl; 2001 Sep; 32():119s-121s. PubMed ID: 11816818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.
    Hubbard R; Venn A
    Thorax; 2000 Oct; 55(10):864-6. PubMed ID: 10992540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: exposure to solvents may cause fibrosing alveolitis.
    Billings CG; Howard P
    Eur Respir J; 1994 Jun; 7(6):1172-6. PubMed ID: 7925888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Britton J
    Eur Respir J; 2000 Sep; 16(3):409-13. PubMed ID: 11028652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Baoku Y; Kalsheker N; Britton J; Johnston I
    Eur Respir J; 1997 Dec; 10(12):2881-3. PubMed ID: 9493678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the aetiology of cryptogenic fibrosing alveolitis.
    Britton J; Hubbard R
    Histopathology; 2000 Nov; 37(5):387-92. PubMed ID: 11119119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational exposure and severe pulmonary fibrosis.
    Gustafson T; Dahlman-Höglund A; Nilsson K; Ström K; Tornling G; Torén K
    Respir Med; 2007 Oct; 101(10):2207-12. PubMed ID: 17628464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cryptogenic fibrosing alveolitis in metal workers.
    Hubbard R; Cooper M; Antoniak M; Venn A; Khan S; Johnston I; Lewis S; Britton J
    Lancet; 2000 Feb; 355(9202):466-7. PubMed ID: 10841131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
    Hubbard R; Johnston I; Britton J
    Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Blue bodies" in a case of cryptogenic fibrosing alveolitis (desquamative type) an ultra-structural study.
    Gardiner IT; Uff JS
    Thorax; 1978 Dec; 33(6):806-13. PubMed ID: 218319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
    Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
    Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan.
    Miyake Y; Sasaki S; Yokoyama T; Chida K; Azuma A; Suda T; Kudoh S; Sakamoto N; Okamoto K; Kobashi G; Washio M; Inaba Y; Tanaka H
    Ann Occup Hyg; 2005 Apr; 49(3):259-65. PubMed ID: 15640309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis.
    Johnston ID; Bleasdale C; Hind CR; Woodcock AA
    Thorax; 1991 Aug; 46(8):589-91. PubMed ID: 1926030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking "cryptogenic" out of fibrosing alveolitis.
    Kennedy S; Chan-Yeung M
    Lancet; 1996 Feb; 347(8997):276-7. PubMed ID: 8569355
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cellulose in wood dust-induced fibrosing alveo-bronchiolitis in rat.
    Tátrai E; Adamis Z; Böhm U; Merétey K; Ungváry G
    J Appl Toxicol; 1995; 15(1):45-8. PubMed ID: 7745224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.